Your browser doesn't support javascript.
loading
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab.
Koguchi, Yoshinobu; Iwamoto, Noriko; Shimada, Takashi; Chang, Shu-Ching; Cha, John; Curti, Brendan D; Urba, Walter J; Piening, Brian D; Redmond, William L.
Afiliação
  • Koguchi Y; Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Iwamoto N; Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA.
  • Shimada T; Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA.
  • Chang SC; Medical Data Research Center, Providence St Joseph Health, Portland, Oregon, USA.
  • Cha J; Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Curti BD; Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Urba WJ; Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Piening BD; Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Redmond WL; Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA william.redmond@providence.org.
J Immunother Cancer ; 9(10)2021 10.
Article em En | MEDLINE | ID: mdl-34620702
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Ipilimumab / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Ipilimumab / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos